<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Increased <z:mp ids='MP_0003674'>oxidative stress</z:mp>, hypofibrinolysis and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> are present in <z:mp ids='MP_0001261'>obese</z:mp> Type 2 diabetic patients </plain></SENT>
<SENT sid="1" pm="."><plain>It is supposed that treatment with <z:chebi fb="11" ids="22586">antioxidant</z:chebi> <z:chebi fb="0" ids="22470">alpha-tocopherol</z:chebi> (vitamin E) could not only decrease free radical production, but also ameliorate insulin action </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated the effect of 3 months administration of vitamin E (600 mg daily) on insulin action examined by hyperinsulinemic clamp in 11 <z:mp ids='MP_0001261'>obese</z:mp> Type 2 diabetic patients </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp> and fibrinolysis were also determined </plain></SENT>
<SENT sid="4" pm="."><plain>The administration of vitamin E caused a decrease of <z:chebi fb="105" ids="17234">glucose</z:chebi> disposal rate (26.6 +/- 9.5 vs 21.3 +/- 7.5 micromol/kg/min, P &lt; 0.02) and of metabolic clearance rate of <z:chebi fb="105" ids="17234">glucose</z:chebi> (3.7 +/- 1.6 vs 2.9 +/- 0.8 ml/kg/min </plain></SENT>
<SENT sid="5" pm="."><plain>P &lt; 0.02) </plain></SENT>
<SENT sid="6" pm="."><plain>A decrease of insulin receptor number was observed on erythrocytes after vitamin E (284 +/- 84 vs 171 +/- 59 pmol/l, P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>Significantly higher plasma malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>) concentration documented an increased <z:mp ids='MP_0003674'>oxidative stress</z:mp> in diabetic patients as compared with healthy persons (3.13 +/- 0.68 vs 1.89 +/- 0.18 micromol/l, P&lt;0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>An inverse relationship was found between <z:chebi fb="14" ids="32506">MDA</z:chebi> concentration and insulin sensitivity expressed by <z:chebi fb="105" ids="17234">glucose</z:chebi> disposal rate (r = -0.73) </plain></SENT>
<SENT sid="9" pm="."><plain>Vitamin E further worsened the hypofibrinolysis documented by a decrease of tissue plasminogen activator (P &lt; 0.01) without changes in its inhibitor PAI-1 </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion. our results demonstrate that higher doses of vitamin E may further deteriorate insulin action and fibrinolysis in <z:mp ids='MP_0001261'>obese</z:mp> Type 2 diabetic patients </plain></SENT>
</text></document>